Advancing understanding of Alzheimer’s disease using multiomics spatial biology
2 2 people viewed this event.
The complexity of biological systems and diseases, such as Alzheimer’s disease, necessitates spatial multiomics techniques to gain a holistic understanding of cell-cell interactions and communication. A singular approach to spatial multiomics is possible with MALDI Imaging, including label-free imaging of small molecules, lipids, drugs, and glycans. Additionally, with technology developed by AmberGen, Inc., photocleavable mass-tag (PCMT) conjugated affinity probes are available for antibodies, oligos, and lectins.
Key Learning Objectives:
- Learn the spatial biology utility of MALDI Imaging
- Understand multiomics workflows and the applications to disease-based research
Who Should Attend:
- Researchers interested in multiomics brain analysis
- Investigators researching Alzheimer’s disease
